Group 1 - The core point of the article is that *ST Meigu (SZ 000615) held its 27th meeting of the 11th Board of Directors on November 5, 2025, to discuss the proposal for the third extraordinary shareholders' meeting in 2025 [1] - For the first half of 2025, *ST Meigu's revenue composition is as follows: medical beauty services accounted for 57.47%, bio-based fibers accounted for 38.54%, and others accounted for 3.99% [1] - As of the report date, *ST Meigu has a market capitalization of 3 billion yuan [1]

Group 1 - The medical beauty sector increased by 0.18% on November 6, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] - The trading volume and turnover for *ST Meigu were 137,900 hands and 53.13 million yuan, respectively, with a price increase of 3.95% [1] Group 2 - The medical beauty sector experienced a net outflow of 34.96 million yuan from main funds, while retail investors saw a net inflow of 36.62 million yuan [1] - Individual stock performances included *ST Meigu with a 3.95% increase, Aimeike with a 0.38% increase, Huaxi Biological with a 0.52% decrease, and Jinbo Biological with a 2.54% decrease [1] - The net fund flow for *ST Meigu was -3.52 million yuan, indicating a decrease of 6.63% [2]

Group 1 - The medical beauty sector experienced a decline of 2.68% on November 4, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] - Major stocks in the medical beauty sector showed varied performance, with *ST Meigu closing at 3.74 (+0.27%), Huaxi Biological at 52.05 (-2.01%), Aimeike at 151.92 (-3.46%), and Jinbo Biological at 243.02 (-4.84%) [1] Group 2 - The medical beauty sector saw a net outflow of 101 million yuan from institutional investors, while retail investors had a net inflow of 79.55 million yuan [1] - The trading volume and turnover for key stocks included *ST Meigu with 140,600 shares traded and a turnover of 53.3 million yuan, Huaxi Biological with 29,200 shares and 153 million yuan, Aimeike with 43,500 shares and 669 million yuan, and Jinbo Biological with 15,400 shares and 378 million yuan [1]

Market Overview - The medical beauty sector experienced a decline of 1.4% on November 3, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Individual Stock Performance - *ST Meigu (000615) closed at 3.73, with an increase of 4.19% and a trading volume of 150,000 shares, totaling a transaction value of 5.5589 million yuan [1] - Jinbo Biological (920982) closed at 255.37, up 1.63%, with a trading volume of 15,700 shares and a transaction value of 403 million yuan [1] - Huaxi Biological (688363) closed at 53.12, down 1.61%, with a trading volume of 29,400 shares and a transaction value of 156 million yuan [1] - Ai Meike (300896) closed at 157.37, down 1.70%, with a trading volume of 33,400 shares and a transaction value of 5.271 billion yuan [1] Capital Flow Analysis - The medical beauty sector saw a net inflow of 2.7789 million yuan from main funds, while retail investors experienced a net outflow of 3.33256 million yuan [1] - Main funds for *ST Meigu showed a net inflow of 6.9892 million yuan, while retail investors had a net outflow of 652.99 thousand yuan [2] - Ai Meike had a net inflow of 1.4812 million yuan from main funds, but a net outflow of 1.89798 million yuan from retail investors [2] - Huaxi Biological experienced a net outflow of 5.6915 million yuan from main funds and a net outflow of 781.58 thousand yuan from retail investors [2]

Core Viewpoint - The medical beauty sector experienced a slight increase of 0.81% on October 31, with Jinbo Biological leading the gains, while the overall market indices saw declines [1]. Group 1: Market Performance - On October 31, the Shanghai Composite Index closed at 3954.79, down 0.81%, and the Shenzhen Component Index closed at 13378.21, down 1.14% [1]. - Jinbo Biological's stock price rose by 2.35% to 251.28, with a trading volume of 16,800 hands and a transaction value of 421 million yuan [1]. - Other notable stocks in the medical beauty sector included *ST Meigu, which increased by 1.42% to 3.58, and Huaxi Biological, which rose by 0.82% to 66.65 [1]. Group 2: Capital Flow - The medical beauty sector saw a net inflow of 5.8151 million yuan from institutional investors, while retail investors experienced a net outflow of 7.1663 million yuan [2]. - The sector also recorded a net inflow of 1.3512 million yuan from speculative funds [2].

Core Insights - The medical beauty sector experienced a decline of 0.81% on October 30, with Jinbo Biological leading the drop at 7.07% [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Medical Beauty Sector Performance - Huaxi Biological closed at 53.55, down 0.70%, with a trading volume of 30,900 shares and a transaction value of 166 million [1] - *ST Meigu closed at 3.53, down 0.84%, with a trading volume of 71,000 shares and a transaction value of 25.09 million [1] - Aimeike closed at 158.89, down 0.89%, with a trading volume of 30,100 shares and a transaction value of 47.9 million [1] - Jinbo Biological closed at 245.50, down 7.07%, with a trading volume of 29,300 shares and a transaction value of 733 million [1] Capital Flow Analysis - The medical beauty sector saw a net outflow of 2.1553 million from main funds, while retail funds experienced a net outflow of 3.2717 million [1] - Speculative funds had a net inflow of 5.4269 million [1] Individual Stock Capital Flow - Aimeike had a net outflow of 15.355 million, down 3.21%, with a net inflow of 21.139 million, down 0.44% [2] - *ST Meigu experienced a net outflow of 5.6326 million, down 22.45%, with a net inflow of 4.3275 million, up 17.25% [2] - Huaxi Biological had a net outflow of 13.9915 million, down 8.41%, with a net inflow of 16.4544 million, up 9.89% [2]

Group 1 - The medical beauty sector experienced a decline of 0.14% on October 29, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] - Key stocks in the medical beauty sector showed varied performance, with Jinbo Biological rising by 7.46% and Ai Meike falling by 1.97% [1] Group 2 - The medical beauty sector saw a net outflow of 23.498 million yuan from main funds, while retail investors had a net inflow of 39.3117 million yuan [1] - Specific stock fund flows indicated that Huaxi Biological had a main fund inflow of 8.119 million yuan, while Ai Meike experienced a significant outflow of 29.5668 million yuan [2] - The overall trend showed that retail investors were more active in the sector, with a net inflow across several stocks despite the main and speculative funds pulling back [2]

Core Insights - *ST Meigu (000615.SZ) released its Q3 2025 financial report on October 29, 2025, indicating a significant presence of institutional investors in its A-shares [1] Institutional Holdings - As of October 28, 2025, four institutional investors disclosed holdings in *ST Meigu, totaling 262 million shares, which represents 34.31% of the company's total share capital [1] - The institutional investors include Shenzhen Aoyuan Kexing Investment Co., Ltd., Jinghan Holdings Group Co., Ltd., Shanghai Tongyi Investment Management Co., Ltd. - Tongyi Wutong No. 22 Private Securities Investment Fund, and Beijing Heliman Tong Information Consulting Center (Limited Partnership) [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.77 percentage points [1]

董事会议事规则 奥园美谷科技股份有限公司 董事会议事规则 第一章 总则 第一条 为进一步规范奥园美谷科技股份有限公司（以下简称"公司"） 董事会 的议事方式和决策程序，促使董事和董事会有效地履行其职责，提高董事会规范运 作和科学决策水平，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《深 圳证券交易所股票上市规则》等法律、行政法规、规范性文件和《奥园美谷科技股份 有限公司章程》（以下简称"《公司章程》"）特制定本规则。 第二条 公司依法设立董事会，董事会是公司的经营决策机构，负责执行股东会 的决议。董事会履行其职责时应严格遵守《公司法》及其他有关法律、行政法规、 部门规章和《公司章程》的规定，公平对待所有股东，并关注其他利益相关者的利 益。公司全体董事应当勤勉尽责，确保董事会正常召开和依法行使职权。 第三条 董事会会议是董事会议事的主要形式。董事按规定参加董事会会议是 履行董事职责的基本方式。 第二章 董事会的组成及职权 第四条 公司董事会由 9 名董事组成，其中独立董事 3 人，独立董事中至少有一 名是会计专业人士，设董事长 1 人，可设副董事长 1 人。 董事长、副董事长由全体董事过半数选举产生 ...

股东会议事规则 奥园美谷科技股份有限公司 股东会议事规则 第一章 总则 第一条 为规范奥园美谷科技股份有限公司（以下简称"公司"）行为，维护公 司及股东的合法权益，保证股东会依法行使职权，规范公司股东会运作，根据《中华 人民共和国公司法》（以下简称"《公司法》"）、《深圳证券交易所股票上市规则》 （以下简称"《上市规则》"）、《深圳证券交易所上市公司自律监管指引第 1 号——主 板上市公司规范运作》、《奥园美谷科技股份有限公司章程》（以下简称"《公司章 程》"）等有关规定，制定本规则。 第二条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相关规定 召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当勤勉 尽责，确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 法定由股东会行使的职权，不得通过授权的形式由董事会或其他机构和个人代为 行使。股东会授权董事会或者其他机构和个人代为行使其他职权的，应当符合法律、 行政法规、部门规章和《公司章程》等规定的授权原则，并明确授权的具体内容。 第四条 股东会分 ...